Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2017 Sep 9;24(1):1273–1283. doi: 10.1080/10717544.2017.1370620

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2017 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group.

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

PMC Copyright notice

Figure 1. — (A) The subretinal delivery pathway of EPO. A 30½-gague beveled needle was used to make an incision near the corneal limbus. The syringe needle of a Hamilton micro injector was inserted into the anterior chamber through the corneal perforation. The plunger of the Hamilton syringe was slowly pushed to deliver the EPO into the subretinal cavity. A successful subretinal injection would cause one or more retinal blebs on which retinal blood vessels were visible. (B) The retinal EPO level of the treated group was significantly higher than the normal controls. The retinal EPO level of the treated group was also significantly higher than the MNU group. The retinal EPO level of the Normal + EPO group was significantly higher than the normal controls (#p < .01 for differences compared between animal groups; All the values were presented as mean ± SD).